It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2022.
2022 | Chandigarh, Chandigarh, India | ActiveElinza Pharmaceuticals Private Limited, a active private limited company, was established on 06 April 2022 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909CH2022PTC044296. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Vikram Khungar (Director), Raj Khurana (Additional Director). Past directors included Dipty Manchanda. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 4-A,, First Floor, Chandigarh, Chandigarh, 160102.
U51909CH2022PTC044296
044296
06 April 2022
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Elinza Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikram Khungar | Director | 06 Apr 2022 | Current |
| Raj Khurana | Additional Director | 25 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Dec 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Elinza Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Elinza Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Elinza Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elinza Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elinza Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Raj Khurana was appointed as a Additional Director was appointed as a Additional Director on 25 Nov 2024 & has been associated with this company since 1 year 5 days . was documented.
Elinza Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Elinza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Vikram Khungar was appointed as a Director was appointed as a Director on 06 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Progress on Elinza Pharmaceuticals Private Limited was registered on 06 Apr 2022 with Roc Chandigarh & aged 3 years 7 months as per MCA records. was documented.
The CIN of Elinza Pharmaceuticals Private Limited is U51909CH2022PTC044296.
Elinza Pharmaceuticals Private Limited is headquartered at Plot No. 4-A,, First Floor, Chandigarh, Chandigarh, 160102.
Elinza Pharmaceuticals Private Limited was incorporated on 06 April 2022.
The current directors of Elinza Pharmaceuticals Private Limited are
The primary industry of Elinza Pharmaceuticals Private Limited is Pharma.
Elinza Pharmaceuticals Private Limited is unlisted.
The authorized capital of Elinza Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX